Interinstitutional variability and effect of tissue fixative on the interpretation of a Barrett cytokeratin 7/20 immunoreactivity pattern in Barrett esophagus.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Human Pathology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.HUMPATH.2004.10.007PMID 15712183
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Distinction between intestinal metaplasia in the cardia and in Barrett's esophagus: the role of histology and immunohistochemistry.

  2004cited by this paper
• Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus

  2002cited by this paper
• Cytokeratin 7/20 immunostaining: Barrett's oesophagus or gastric intestinal metaplasia?

  2002cited by this paper
• Barrett's esophagus.

  2002cited by this paper
• Utilization of Cytokeratins 7 and 20 Does Not Differentiate between Barrett's Esophagus and Gastric Cardiac Intestinal Metaplasia

  2002cited by this paper
• Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology

  2001cited by this paper
• Immunohistochemical markers for Barrett's esophagus and associations to esophageal Z-line appearance.

  2001cited by this paper
• Cytokeratin subsets for distinguishing barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens

  2001cited by this paper
• Phenotype of Barrett's Esophagus and Intestinal Metaplasia of the Distal Esophagus and Gastroesophageal Junction: An Immunohistochemical Study of Cytokeratins 7 and 20, Das-1 and 45MI

  2001cited by this paper
• Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus.

  2000cited by this paper
• Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia

  2000cited by this paper
• Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach.

  1999cited by this paper
• Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data.

  1999cited by this paper
• Effects of fixation and tissue processing on immunohistochemical demonstration of specific antigens.

  1996cited by this paper
• Practical statistics for medical research

  1990cited by this paper
• Immunohistochemical demonstration of estrogen receptors (ER) in formalin-fixed, paraffin-embedded human breast cancer tissue by use of a monoclonal antibody to ER.

  1988cited by this paper
• A Coefficient of Agreement for Nominal Scales

  1960cited by this paper

• The evolution of approaches to the diagnosis and treatment of patients with Barrett’s esophagus

  2020cites this paper
• Эволюция подходов к диагностике и лечению пациентов с пищеводом Барретта

  2020cites this paper
• Tissue Sampling, Specimen Handling, and Laboratory Processing

  2019cites this paper
• Porcine Esophageal Submucosal Gland Culture Model Shows Capacity for Proliferation and Differentiation

  2017cites this paper
• Columnar Metaplasia in the Esophageal Remnant After Esophagectomy: A Common Occurrence and a Valuable Insight Into the Development of Barrett Esophagus

  2016cites this paper
• A Comprehensive and Contemporary Review for Pathologists

  2016cites this paper
• Barrett's oesophagus diagnostic criteria: endoscopy and histology.

  2015cites this paper
• Barrett esophagus: diagnostic challenges.

  2014cites this paper
• The incidence and pathogenesis of 'recurrent' Barrett's metaplasia following oesophagectomy (neo-Barrett's)

  2013cites this paper
• 5. Barrett's Oesophagus

  2012cites this paper
• What the gastroenterologist needs to know about the histology of Barrett's esophagus

  2011cites this paper
• CHAPTER 20 – Esophagus

  2009cites this paper
• Immunoreactivity of cytokeratins 7 and 20 in goblet cells and columnar blue cells in patients with endoscopic evidence of Barrett's esophagus.

  2009cites this paper
• Pathologic Implications of Prostate Biopsy

  2008cites this paper
• Two cases of eosinophilic vasculitis with thrombosis

  2008cites this paper
• CDX2 and villin are useful markers of intestinal metaplasia in the diagnosis of Barrett esophagus.

  2008cites this paper
• The Use of Cytokeratin Stain to Distinguish Barrett’s Esophagus from Contiguous Tissues: A Systematic Review

  2007cites this paper
• Immunopathological patterns of the stomach in adenocarcinoma of the esophagus, cardia, and gastric antrum: gastric profiles in Siewert type I and II tumors.

  2007cites this paper
• Barrett’s esophagus and Barrett’s carcinoma

  2007cites this paper
• mmunopathological Patterns of the Stomach in denocarcinoma of the Esophagus, Cardia, and astric Antrum: Gastric Profiles in Siewert Type I nd II Tumors

  2007cites this paper
• Morphologic Features are Useful in Distinguishing Barrett Esophagus From Carditis With Intestinal Metaplasia

  2007cites this paper
• Pathologic risk factors of adenocarcinoma of the gastric cardia and gastroesophageal junction.

  2006cites this paper
• Pathology of the gastroesophageal junction.

  2005cites this paper
• Surveillance and screening for Barrett's esophagus: What to do when we have so many patients and so little evidence

  2005cites this paper
• Unraveling the Mystery of the Gastroesophageal Junction: A Pathologist's Perspective

  2005cites this paper